Michael Gerard Campbell - 15 Jun 2022 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.

Role
Chief Financial Officer
Signature
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
Issuer symbol
CMRA on OTC
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 16:59:28 UTC
Previous filing
17 Jun 2022
Next filing
12 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRA Stock Option (Right to Purchase) Award $0 +450,000 $0.000000 450,000 15 Jun 2022 Common Stock 450,000 $3.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest over four (4) years, with twenty-five percent (25%) of the shares of Common Stock underlying the option vesting on June 15, 2023 and the remainder vesting in equal monthly installments thereafter.